May & Baker of Nigeria Plc, the nation’s second-biggest pharmaceuticals maker by market value, had the longest series of gains in three years as it prepares to start vaccine production through a government joint venture.
The stock climbed 4.6 percent to 2.04 naira by the close in Lagos, an 11th day of advances and the longest winning streak since May 2009.
